End-of-day quote
Other stock markets
|
||
- USD | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey W. Greve
DFI | Director of Finance/CFO | 49 | 11-01-31 |
Jerry Webb
COO | Chief Operating Officer | - | 17-12-31 |
Corporate Officer/Principal | - | 06-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Frank Kung
BRD | Director/Board Member | 75 | 06-04-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 32,910,475 | 32,180,075 ( 97.78 %) | 0 | 97.78 % |
Company contact information
Sagent Pharmaceuticals, Inc.
1901 North Roselle Road Suite 450
60195, Schaumburg
+
http://www.sagentpharma.comSector
1st Jan change | Capi. | |
---|---|---|
+34.35% | 705B | |
+29.39% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+14.11% | 238B | |
-3.03% | 210B | |
+10.02% | 209B | |
+9.21% | 169B |
- Stock Market
- Equities
- Stock
- Company Sagent Pharmaceuticals Inc